Psychiatry and Clinical Psychopharmacology
Title Abbreviation
Psychiatry Clin Psychopharmacol
Readership
Clinical Pharmacologists, Clinicians, Mental Health Evaluators, Molecular Biologists, Neurologists, Neuroscientists, Pharmacologists, Physiologists, Psychiatric Nurses, Psychiatrists, Psychologists, Psychotherapists, Residents, Scientists
Scope
Psychiatry and Clinical Psychopharmacology aims to reach a national and international audience and will accept submissions from authors worldwide. It gives high priority to original studies of interest to clinicians and scientists in applied and basic neurosciences and related disciplines. Psychiatry and Clinical Psychopharmacology publishes high quality research targeted to specialists, residents and scientists in psychiatry, psychology, neurology, pharmacology, molecular biology, genetics, physiology, neurochemistry, and related sciences.
Topics of current interest to clinical, experimental and basic scientists are published in critical subjects, such as psychopharmacology, psychiatry and behavioral science. Psychiatry and Clinical Psychopharmacology effectively bridges the gap between basic science and clinical application. Access to the Journal is available to all interested persons with no subscription fees, furthering the aim of reaching all interested national and international associations and individuals.
Sponsoring Association(s)
Turkish Association for Psychopharmacology (TAP)
Publisher Name
Taylor & Francis, Inc. - UK
To see more details about Psychiatry and Clinical Psychopharmacology,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Frequency
Journal Contact
Author Submission Guidelines